Completed NA INTERVENTIONAL 3-arm NCT05493553

Effects of an Intermittent Fasting and Dietary Supplement Regimen on Glycemic Variability

Effects of an Intermittent Fasting and Dietary Supplement Regimen on Glycemic Variability and Glycemic Control in Men and Women With Risk Factors for Impaired Fasting Glucose: A Sub-chronic Continuous Glucose Monitoring Pilot Study

Sponsor: Biofortis Innovation Services

Conditions Healthy Impaired Glucose Tolerance

Interventions Dietary supplement and intermittent fasting regimen Dietary supplement regimen

Updated 4 times since 2022 Last updated: Oct 31, 2022 Started: Aug 8, 2022 Primary completion: Sep 29, 2022 Completion: Sep 29, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Healthy and Impaired Glucose Tolerance, this trial is completed. The trial is conducted by Biofortis Innovation Services and has accumulated 4 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Dec 2022 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Sep 2022 — Dec 2022 [monthly]

Recruiting NA

First recorded

Aug 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Biofortis Innovation Services
Unicity International, Inc.

Data source: Unicity International, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Addison, United States